Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ReSScue: ACHIM for GI Symptoms in Systemic Sclerosis
NCT04300426Phase 2Completed
- Sponsor
- Oslo University Hospital
- Start
- Sep 2020
- Primary completion
- Jun 2022
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of anaerobically cultivated human intestinal microbiota in systemic sclerosis (SSc), sponsored by Oslo University Hospital. Primary endpoint: Change from baseline to week 12 in UCLA GIT score item diarrhea or bloating. Started Sep 2020; status: completed.
02
Drugs
anaerobically cultivated human intestinal microbiota
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on NCT04300426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04300426.